News | 06 December 2012
VANCOUVER - Pharmaceutical giant GlaxoSmithKline says it conducted its clinical trial program for the anti-depressant drug Paxil appropriately in marketing the medicine for use by women of childbearing age. The statement comes after a B.C. Supreme ...
Click on the link to read the full article at Vancouver Sun
(This link will open in a new window)